BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37540307)

  • 21. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women.
    Atallah D; El Kassis N; Safi J; El Hachem H; Chahine G; Moubarak M
    Arch Gynecol Obstet; 2021 Nov; 304(5):1299-1305. PubMed ID: 33830345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing ovarian stimulation with letrozole and levonorgestrel intrauterine system after combined fertility-sparing approach for atypical endometrial lesions: a retrospective case-control study.
    Gallo A; Di Spiezio Sardo A; Conforti A; Iorio GG; Zizolfi B; Buonfantino C; De Angelis MC; Strina I; Marrone V; Bifulco G; Alviggi C
    Reprod Biomed Online; 2024 May; 48(5):103750. PubMed ID: 38430660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus No. 5.
    Obstet Gynecol; 2023 Sep; 142(3):735-744. PubMed ID: 37590985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can malignant potential of endometrial polyps be determined by incorporating the endometrial intraepithelial neoplasia (EIN) classification?
    Naaman Y; Diment J; Perlman S; Oustinov N; Vaisbuch E; Ben-Arie A
    Gynecol Oncol; 2015 Feb; 136(2):254-7. PubMed ID: 25524459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical efficacy and pregnancy outcomes of fertility-preserving re-treatment after recurrence of the patient with atypical endometrial hyperplasia and early stage endometrial carcinoma].
    He YJ; Wang YQ; Tang HR; He M; Rao Y; Zhou R; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jan; 55(1):21-28. PubMed ID: 32074769
    [No Abstract]   [Full Text] [Related]  

  • 26. A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma.
    Guillon S; Popescu N; Phelippeau J; Koskas M
    Int J Gynaecol Obstet; 2019 Sep; 146(3):277-288. PubMed ID: 31197826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
    De Rocco S; Buca D; Oronzii L; Petrillo M; Fanfani F; Nappi L; Liberati M; D'Antonio F; Scambia G; Leombroni M; Dessole M; Lucidi A
    Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():90-97. PubMed ID: 35526471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis.
    Chae-Kim J; Garg G; Gavrilova-Jordan L; Blake LE; Kim TT; Wu Q; Hayslip CC
    Int J Gynecol Cancer; 2021 Dec; 31(12):1499-1505. PubMed ID: 34785524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of levonorgestrel-releasing intrauterine device in the treatment of atypical endometrial hyperplasia and early endometrial cancer.
    Hirata T; Kondo E; Magawa S; Kubo-Kaneda M; Nii M; Yoshida K; Maezawa T; Tabata T; Ikeda T
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3219-3225. PubMed ID: 36054237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncologic, fertility, and obstetric outcomes with MPA therapy in women with endometrial cancer and atypical endometrial hyperplasia.
    Takeda A; Yamamoto Y; Tamura K; Aoki H; Noguchi H; Minato S; Kamada S; Arakaki R; Kaji T; Iwasa T
    J Obstet Gynaecol Res; 2024 Apr; 50(4):633-638. PubMed ID: 38154145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer.
    Guan J; Chen XJ
    Front Endocrinol (Lausanne); 2022; 13():1041535. PubMed ID: 36387903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fertility-sparing management for endometrial cancer: review of the literature.
    Garzon S; Uccella S; Zorzato PC; Bosco M; Franchi MP; Student V; Mariani A
    Minerva Med; 2021 Feb; 112(1):55-69. PubMed ID: 33205638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of coexisting endometrial carcinoma in case of atypical endometrial hyperplasia diagnosed on total hysteroscopic resection.
    Pivano A; Crochet P; Carcopino X; Cravello L; Boubli L; Agostini A
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():210-3. PubMed ID: 27343737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive Accuracy of Progesterone Receptor B in Young Women with Atypical Endometrial Hyperplasia and Early Endometrial Cancer Treated with Hysteroscopic Resection plus LNG-IUD Insertion.
    Raffone A; Travaglino A; Zullo FM; Gencarelli A; Micheli M; Miranda S; De Franciscis P; Insabato L; Di Spiezio Sardo A; Zullo F; Bifulco G
    J Minim Invasive Gynecol; 2021 Jun; 28(6):1244-1253. PubMed ID: 33122144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
    BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
    Pronin SM; Novikova OV; Andreeva JY; Novikova EG
    Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study.
    Raffone A; Catena U; Travaglino A; Masciullo V; Spadola S; Della Corte L; Piermattei A; Insabato L; Zannoni GF; Scambia G; Zullo F; Bifulco G; Fanfani F; Di Spiezio Sardo A
    Gynecol Oncol; 2021 Jun; 161(3):795-801. PubMed ID: 33812697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The optimal time for the initiation of in vitro fertilization and embryo transfer among women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertility-sparing treatment.
    Song Z; Liu H; Zhou R; Xiao Z; Wang J; Wang H; Lu Q
    Arch Gynecol Obstet; 2022 May; 305(5):1215-1223. PubMed ID: 34762188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/endometrial cancer: Wait or treat!
    İşçi Bostancı E; Durmuş Y; Duru Çöteli AS; Kayıkçıoğlu F; Boran N
    Turk J Med Sci; 2021 Aug; 51(4):2066-2072. PubMed ID: 34013707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation.
    Dagher C; Manning-Geist B; Ellenson LH; Weigelt B; Rios-Doria E; Barry D; Abu-Rustum NR; Leitao MM; Mueller JJ
    Gynecol Oncol; 2023 Dec; 179():180-187. PubMed ID: 37992549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.